Clinical Trial

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

Name: CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD — clinical trial record (NCT05609916)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.

Protocol Amendment History 1 change

notable Primary completion pushed: 2026-12-30 -> 2027-07-30 2026-08-05

Trial Details

NCT Number	NCT05609916
Lead Sponsor	Baylor College of Medicine
Conditions	Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder, Obsessive-Compulsive Disorder in Children, Obsessive-Compulsive Disorder in Adolescence
Enrollment	200 participants
Start Date	2022-11-30
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-04